The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Severgina L.O.

I.M. Sechenov First Moscow State Medical University (Sechenov University) of the Ministry of Health of Russia

Kislyakov D.A.

Voskresensk district hospital No. 2

Korovin I.A.

I.M. Sechenov First Moscow State Medical University (Sechenov University) of the Ministry of Health of Russia

Sorokin N.I.

Lomonosov Moscow State University

Interpretation of biopsy material after transuretral and laser en bloc resection of non-muscle-invasive bladder cancer

Authors:

Severgina L.O., Kislyakov D.A., Korovin I.A., Sorokin N.I.

More about the authors

Read: 7115 times


To cite this article:

Severgina LO, Kislyakov DA, Korovin IA, Sorokin NI. Interpretation of biopsy material after transuretral and laser en bloc resection of non-muscle-invasive bladder cancer. Russian Journal of Archive of Pathology. 2022;84(3):32‑39. (In Russ.)
https://doi.org/10.17116/patol20228403132

Recommended articles:

References:

  1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):227-300. 
  2. IARC. Cancer Today. Estimated number of new cases in 2020, worldwide, both sexes, all ages. 2021.
  3. Axel EM, Matveev VB. Statistics of malignant tumors of urinary and male urogenital organs in Russia and the countries of the former USSR. Oncourologia. 2019;15(2):15-24. (In Russ.). https://doi.org/10.17650/1726-9776-2019-15-2-15-24
  4. Glukhov AI, Polotdykova NV, Gordeev SA, Vinarov AZ, Polyakovsky KA, Rapoport LM, Tsarichenko DG, Enikeev DV, Glybochko PV. Modern trends in the diagnosis of bladder cancer. Urologia. 2018;(5):100-105. (In Russ.). https://doi.org/10.18565/urology.2018.5.100-105
  5. Compérat E, Larré S, Roupret M, Neuzillet Y, Pignot G, Quintens H, Houéde N, Roy C, Durand X, Varinot J, Vordos D, Rouanne M, Bakhri MA, Bertrand P, Jeglinschi SC, Cussenot O, Soulié M, Pfister C. Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old. Virchows Archiv. 2015;466(5):589-594.  https://doi.org/10.1007/s00428-015-1739-2
  6. Paner GP, Montironi R, Amin MB. Challenges in pathologic staging of bladder cancer: proposals for fresh approaches of assessing pathologic stage in light of recent studies and observations pertaining to bladder histoanatomic variances. Adv Anat Pathol. 2017;24:113.  https://doi.org/10.1097/PAP.0000000000000152
  7. Mariappan P, Zachou A, Grigor KM; Edinburgh Uro-Oncology Group. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol. 2010;57(5):843-849.  https://doi.org/10.1016/j.eururo.2009.05.047
  8. EAU Guidelines. Edn. presented at the EAU Annual Congress. Milan, Italy; 2021.
  9. Hua Liang, Tao Yang, Kaijie Wu, Dalin He, Jinhai Fan. En bloc resection improves the identification of muscularis mucosae in non-muscle invasive bladder cancer. World J Urol. 2019;37(12): 2677-2682. https://doi.org/10.1007/s00345-019-02672-3
  10. Alekseev BY, Andreeva YuYu, Novikova IV. Prognostic factors of survival in non-muscle-invasive bladder cancer. Oncourologia. 2013;9(1):34-42. (In Russ.).
  11. Ministerstva zdravookhraneniya Rossiiskoi Federatsii (protokol ot 20.12.19. №10/2-3-4)». Russian clinical recommendations. Bladder cancer. 2020. (In Russ.).
  12. Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR, Pruthi R, Quale DZ, Ritch CR, Seigne JD, Skinner EC, Smith ND, McKiernan JM. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J Urol. 2016;196(4):1021-1029. https://doi.org/10.1016/j.juro.2016.06.049
  13. NCCN Guidelines. Version 3.2021.
  14. Rolevich AI. Impact of a surgeon on the relapse-free survival of patients with non-muscle-invasive bladder cancer. Oncourologia. 2016;12(2):40-52. (In Russ.). https://doi.org/10.17650/1726-9776-2016-12-2-40-52
  15. Herr HW, Reuter VE. Evaluation of new resectoscope loop for transurethral resection of bladder tumours. J Urol. 1998;159:2067-2068. https://doi.org/10.1016/S0022-5347(01)63249-X
  16. Lagerveld BW, Koot RA, Smits GA. Thermal artifacts in bladder tumours following loop endoresection: Electrovaporization vs. electrocauterization. J Endourol. 2004;18:583-586. 
  17. Truong M, Liang L, Kukreja J, O’Brien J, Jean-Gilles J, Messing E. Cautery artifact understages urothelial cancer at initial transurethral resection of large bladder tumours. Can Urol Assoc J. 2017; 11(5):203-206.  https://doi.org/10.5489/cuaj.4172
  18. Paner GP, Brown JG, Lapetino S, Nese N, Gupta R, Shen SS, Hansel DE, Amin MB. Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumour (TURBT) specimens. Am J Surg Pathol. 2010;34(6):792-799.  https://doi.org/10.1097/PAS.0b013e3181da7650
  19. Venkatramani V, Panda A, Manojkumar R, Kekre NS. Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled trial. J Urol. 2014;191(6):1703-1707. https://doi.org/10.1016/j.juro.2013.12.004
  20. Wang DS, Bird VG, Leonard VY, Plumb SJ, Konety B, Williams RD, Winfield HN. Use of bipolar energy for transurethral resection of bladder tumours: Pathologic considerations. J Endourol. 2004;18(6):578-582.  https://doi.org/10.1089/end.2004.18.578
  21. Severgina LO, Sorokin NI, Dymov AM, Tsarichenko DG, Enikeev DV, Kislyakov DA, Rapoport LM, Korovin IA, Korolev DO. laser en-bloc resection of non-muscle-invasive bladder cancer: clinical and morphological specificities. Oncourologia. 2018;14(3):78-84.  https://doi.org/10.17650/1726-9776-2018-14-3-78-84
  22. Kovylina MV, Prilepskaya EA, Tupikina NV, Tsybulya OA, Reva IA. Grading of urothelial carcinoma of the bladder. Oncourologia. 2017;13(2):87-95. (In Russ.). https://doi.org/10.17650/1726-9776-2017-13-2-87-95
  23. Sylvester RJ, Rodríguez O, Hernández V, Turturica D, Bauerová L, Bruins HM, Bründl J, van der Kwast TH, Brisuda A, Rubio-Briones J, Seles M, Hentschel AE, Kusuma VRM, Huebner N, Cotte J, Mertens LS, et al. European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: An update from the EAU NMIBC guidelines panel. Eur Urol. 2021;79(4):480-488. 
  24. Abd El-Latif A, Watts KE, Elson P, et al. The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy. J Urol. 2013; 189:1263-1267. https://doi.org/10.1016/j.juro.2012.10.054
  25. Shah RB, Montgomery JS, Montie JE, Kunju LP. Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: Impact of mandatory central pathology review at a large referral hospital. Eur Urol Oncol. 2013;31:1650-1655.
  26. Brierley JD, Gospodarowicz MK, Wittekind C, eds. TNM classification of malignant tumors. UICC International Union Against Cancer. 8th ed. Wiley-Blackwell; 2017.
  27. Gendy R, Delprado W, Brenner P, Brooks A, Coombes G, Cozzi P, Nash P, Patel MI. Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series. BJU Int. 2016; 117(suppl 4):54-59.  https://doi.org/10.1111/bju.13265
  28. Neuzillet Y, Methorst C, Schneider M, Lebret T, Rouanne M, Radulescu C, Molinie V, Dreyfus JF, Pelcat V, Botto H. Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non-muscle-invasive bladder cancer with positive results on urine cytology. Urol Oncol. 2014;32(8):1135-1140. https://doi.org/10.1016/j.urolonc.2014.04.005
  29. Figurin KM. intravesical bcg therapy for non-muscle invasive bladder cancer. Oncourologia. 2012;8(1):14-22. (In Russ.).
  30. May M, Bastian PJ, Brookman-May S, Burger M, Bolenz C, Trojan L, Michel MS, Herrmann E, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, et al. Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder. Scand J Urol Nephrol. 2011;45(4):251-257.  https://doi.org/10.3109/00365599.2011.562235
  31. Turker P, Bostrom PJ, Wroclawski ML, van Rhijn B, Kortekangas H, Kuk C, Mirtti T, Fleshner NE, Jewett MA, Finelli A, Kwast TV, Evans A, Sweet J, Laato M, Zlotta AR. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome. BJU Int. 2012;110(6): 804-811.  https://doi.org/10.1111/j.1464-410X.2012.10939.x
  32. Hurle R, Lazzeri M, Colombo P, Buffi N, Morenghi E, Peschechera R, Castaldo L, Pasini L, Casale P, Seveso M, Zandegiacomo S, et al. “En Bloc” Resection of Nonmuscle Invasive Bladder Cancer: A Prospective Singlecenter Study. Urology. 2016;90:126-130.  https://doi.org/10.1016/j.urology.2016.01.004
  33. Kramer MW, Rassweiler JJ, Klein J, Martov A, Baykov N, Lusuardi L, Janetschek G, Hurle R, Wolters M, Abbas M, et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol. 2015;33(12):1937-1943. https://doi.org/10.1007/s00345-015-1568-6
  34. Maruniak NA, Takezawa K, Murphy WM. Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling. J Urol. 2002;167(6):2404-2407.
  35. Migliari R, Buffardi A, Ghabin H. Thulium Laser endoscopic En bloc enucleation of nonmuscle-invasive bladder cancer. J Endourol. 2015;29(11):1258-1262. https://doi.org/10.1089/end.2015.0336
  36. Xin-Ru Zhang, Chao Feng, Wei-Dong Zhu, Jie-Min Si, Bao-Jun Gu, Hui Guo, Lu-Jie Song, Chao Li. Two micrometer continuous-wave thulium laser treating primary non-muscle-invasive bladder cancer: is it feasible? A randomized prospective study. Photom Laser Surg. 2015;33(10):517-523.  https://doi.org/10.1089/pho.2015.3913
  37. Eissa A, Zoeir A, Ciarlariello S, Sarchi L, Sighinolfi MC, Ghaith A, Puliatti S, Inzillo R, Reggiani Bonetti L, Rizzo M, Rocco B, Micali S. En-bloc resection of bladder tumors for pathological staging: the value of lateral margins analysis. Minerva Urol Nephrol. 2020;72(6):763-769.  https://doi.org/10.23736/S0393-2249.20.03551-1
  38. Hermann G, Horn T, Steven K. The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer. J Urol. 1998;159(1):91-94.  https://doi.org/10.1016/s0022-5347(01)64021-7
  39. Shariat S, Gontero P, Catto JWF. How to treat a patient with T1 High-grade disease and no tumour on repeat transurethral resection of the bladder? Eur Urol Oncol. 2021;4(4):663-669.  https://doi.org/10.1016/j.euo.2019.07.006
  40. Compérat E, Egevad L, Lopez-Beltran A, Camparo P, Algaba F, Amin M, Epstein JI, Hamberg H, Hulsbergen-van de Kaa C, et al. An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps. Histopathology. 2013;63(6):756-766.  https://doi.org/10.1111/his.12214.
  41. Ulyanin MM, Basiashvili GT, Khasanov RS, Gataullin IG, Burmistrov MV, Khayrullina GR. Significance of muscularis mucosae on the risk of recurrence and progression in patients with superficial bladder cancer. Oncourologia. 2015;11(4):42-50. (In Russ.). https://doi.org/10.17650/1726-9776-2015-11-4-42-50
  42. Compérat EM, Burger M, Gontero P, Mostafid AH, Palou J, Rouprêt M, van Rhijn BWG, Shariat SF, Sylvester RJ, Zigeuner R, Babjuk M. Grading of urothelial carcinoma and the new «World Health Organisation classification of tumours of the urinary system and male genital organs 2016». Eur Urol Focus. 2019;5(3):457-466.  https://doi.org/10.1016/j.euf.2018.01.003
  43. Substaging T1 disease (Recommended). https://www.iccr-cancer.org/datasets/docs/iccr-utbiopsy-substaging
  44. Orsola A, Werner L, de Torres I, Martin-Doyle W, Raventos CX, Lozano F, Mullane SA, Leow JJ, Barletta JA, Bellmunt J, Morote J. (2015). Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients. Br J Cancer. 2015;112(3):468-474. 
  45. Kardoust Parizi M, Enikeev D, Glybochko PV, Seebacher V, Janisch F, Fajkovic H, Chłosta PL, Shariat SF. Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis. World J Urol. 2020;38(6):1437-1449. https://doi.org/10.1007/s00345-019-02936-y
  46. Herrmann TR, Wolters M, Kramer MW. Transurethral en bloc resection of nonmuscle invasive bladder cancer: trend or hype. Curr Opin Urol. 2017;27:182-190.  https://doi.org/10.1097/MOU.0000000000000377

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.